Buprenorphine And Naloxone Tablet
Product Images NDC 71335-1296

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 71335-1296). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine Chemical Structure (Buprenorphine And Naloxone Sublingual Tablets 1)

Chemical structure of Buprenorphine Hydrochloride depicted with atoms and bonds including functional groups and a hydrochloride (HCl) indicator.*

FDA Label Image

Naloxone Chemical Structure (Buprenorphine And Naloxone Sublingual Tablets 2)

Chemical structure diagram of the active ingredient Buprenorphine. The diagram shows the molecular framework with labeled functional groups and bonds, including a phenol group, hydroxyl groups, and an amine side chain.*

FDA Label Image

Tablet Placement (Buprenorphine And Naloxone Sublingual Tablets 3)

An illustration shows a close-up of a person’s open mouth with two tablets placed on the tongue. The image demonstrates the sublingual administration of medication, relevant to tablets like Buprenorphine and Naloxone sublingual tablets.*

FDA Label Image

Label Image (Lbl713351296)

Packaging label for Buprenorphine and Naloxone sublingual tablets, 2 mg/0.5 mg strength, labeled by Bryant Ranch Prepack. The label includes a pink hexagon symbol, storage instructions for room temperature (20°-25°C), a warning to keep drugs out of reach of children, and a package size of 30 tablets. The NDC number 71335-1296 is shown along with a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.